Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has issued an update.
Piramal Pharma Limited successfully conducted its 5th Annual General Meeting (AGM) on July 30, 2025, via video conference, ensuring compliance with regulatory guidelines. All proposed resolutions were passed with the requisite majority, demonstrating strong shareholder support and effective governance practices. The AGM proceedings were webcast for transparency, and e-voting facilities were provided to facilitate shareholder participation, reflecting the company’s commitment to leveraging technology for stakeholder engagement.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its comprehensive product portfolio and services, catering to various market needs in the healthcare sector.
Average Trading Volume: 244,227
Technical Sentiment Signal: Hold
Current Market Cap: 271.6B INR
Learn more about PPLPHARMA stock on TipRanks’ Stock Analysis page.